521. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
作者: Pia Moinzadeh.;Francesco Bonella.;Max Oberste.;Jithmi Weliwitage.;Nobert Blank.;Gabriela Riemekasten.;Ulf Müller-Ladner.;Jörg Henes.;Elise Siegert.;Claudia Günther.;Ina Kötter.;Christiane Pfeiffer.;Marc Schmalzing.;Gabriele Zeidler.;Peter Korsten.;Laura Susok.;Aaron Juche.;Margitta Worm.;Ilona Jandova.;Jan Ehrchen.;Cord Sunderkötter.;Gernot Keyßer.;Andreas Ramming.;Tim Schmeiser.;Alexander Kreuter.;Hanns-Martin Lorenz.;Nicolas Hunzelmann.;Michael Kreuter.
来源: Chest. 2024年165卷1期132-145页
Pulmonary involvement is the leading cause of death in systemic sclerosis (SSc) and may manifest as interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), or in combination of both (ILD with pulmonary hypertension [ILD-PH]). The aim of this analysis was to determine prevalence, clinical characteristics, and survival of these different forms within the registry of the German Network for Systemic Sclerosis.
522. Effect of Admission and Onset Time on the Prognosis of Patients With Cardiogenic Shock.
作者: Michael Behnes.;Jonas Rusnak.;Sascha Egner-Walter.;Marinela Ruka.;Jonas Dudda.;Alexander Schmitt.;Jan Forner.;Kambis Mashayekhi.;Péter Tajti.;Mohamed Ayoub.;Christel Weiß.;Ibrahim Akin.;Tobias Schupp.
来源: Chest. 2024年165卷1期110-127页
The spectrum of patients with cardiogenic shock (CS) has changed significantly over time. CS has become especially more common in the absence of acute myocardial infarction (AMI), while this subset of patients was typically excluded from recent studies. Furthermore the prognostic impact of onset time and onset place due to CS has rarely been investigated.
523. Low-Dose vs Conventional-Dose Trimethoprim-Sulfamethoxazole Treatment for Pneumocystis Pneumonia in Patients Not Infected With HIV: A Multicenter, Retrospective Observational Cohort Study.
作者: Tatsuya Nagai.;Hiroki Matsui.;Haruka Fujioka.;Yuya Homma.;Ayumu Otsuki.;Hiroyuki Ito.;Shinichiro Ohmura.;Toshiaki Miyamoto.;Daisuke Shichi.;Watari Tomohisa.;Yoshihito Otsuka.;Kei Nakashima.
来源: Chest. 2024年165卷1期58-67页
Trimethoprim-sulfamethoxazole (TMP-SMX) is an effective treatment for Pneumocystis jirovecii pneumonia (PCP) in immunocompromised patients with and without HIV infection; however, a high incidence of adverse events has been observed. Low-dose TMP-SMX is a potentially effective treatment with fewer adverse events; however, evidence is limited.
524. Comparative Effectiveness of First-Line and Alternative Antibiotic Regimens in Hospitalized Patients With Nonsevere Community-Acquired Pneumonia: A Multicenter Retrospective Cohort Study.
作者: Anthony D Bai.;Siddhartha Srivastava.;Benjamin K C Wong.;Geneviève C Digby.;Fahad Razak.;Amol A Verma.
来源: Chest. 2024年165卷1期68-78页
There are several antibiotic regimens to treat community-acquired pneumonia (CAP).
525. Association of Metabolic Syndrome With Risk of Lung Cancer: A Population-Based Prospective Cohort Study.
作者: Mengmeng Li.;Su-Mei Cao.;Niki Dimou.;Lan Wu.;Ji-Bin Li.;Jun Yang.
来源: Chest. 2024年165卷1期213-223页
Both the incidence of lung cancer and the prevalence of metabolic syndrome (MetS) have been increasing worldwide. The relationship between MetS and lung cancer remains controversial.
526. Multiplex Polymerase Chain Reaction Assay to Detect Nasopharyngeal Viruses in Immunocompromised Patients With Acute Respiratory Failure.
作者: Alexis Maillard.;Jérôme Le Goff.;Mariame Barry.;Virginie Lemiale.;Séverine Mercier-Delarue.;Alexandre Demoule.;Linda Feghoul.;Samir Jaber.;Kada Klouche.;Achille Kouatchet.;Laurent Argaud.;Francois Barbier.;Naike Bigé.;Anne-Sophie Moreau.;Emmanuel Canet.;Frédéric Pène.;Maud Salmona.;Djamel Mokart.;Elie Azoulay.
来源: Chest. 2023年164卷6期1364-1377页
In immunocompromised patients with acute respiratory failure (ARF), the clinical significance of respiratory virus detection in the nasopharynx remains uncertain.
527. Sepsis in Immunocompromised Host and a Hematologic Complication.
作者: Anatoliy Korzhuk.;Iulia Kovalenko.;Kripa Rajak.;Martin Cuevas.;Konstantin Golubykh.;Michaela Sangillo.;Sudhamshi Toom.;Navitha Ramesh.
来源: Chest. 2023年164卷2期e47-e55页
A 43-year-old Puerto Rican man with a kidney transplant presented to the ED with 2 weeks of flu-like symptoms, nausea, and vomiting. He had plasma exchange therapy 2 months before for acute transplant rejection and has been tolerating a heightened immunosuppressive regimen. CT scans characterized opacities as possibly early tree-in-bud opacities (Fig 1A). Patient remained stable throughout hospital stay with an unremarkable workup and was discharged with doxycycline for nonspecific pneumonia.
528. An 80-Year-Old Man With Respiratory Insufficiency After Intravesical Mycobacterium bovis BCG Immunotherapy.
作者: Dolly Haselager.;Wendelien Dorigo-Zetsma.;Michael Schröder.;Jeroen Heidt.
来源: Chest. 2023年164卷2期e39-e43页
An 80-year-old man came to the ED with fever, hematuria, and overall discomfort for 1 week. His medical history included a superficial urothelial carcinoma of the bladder for which he was adjunctively treated with intravesical Mycobacterium bovis BCG (bacillus Calmette-Guérin) immunotherapy for several months. The patient was admitted to the hospital and was initially treated with cephalosporins for a suspected complicated urinary tract infection, but his symptoms did not improve. Ten days after the initial admission, the patient developed hypoxemic respiratory failure during an episode of fever and cold chills and was admitted to the ICU.
529. A 53-Year-Old Woman With Seizure and Cavitary Lung Mass.
A 53-year-old woman with no significant past medical history came to her local ED after a witnessed generalized tonic-clonic seizure. CT scan imaging of the head revealed a left frontal lobe hypodensity concerning for a mass with surrounding edema. In the previous month, she had undergone ambulatory evaluation for a subacute cough that had more recently become productive of bloody sputum. Outpatient chest radiography had demonstrated a new right lung opacity, shown on subsequent CT scan imaging to be a right upper lobe (RUL) consolidation. She was prescribed a course of doxycycline, after which sputum expectoration improved but a nonproductive cough remained. Repeat thoracic imaging was pending at the time the seizure occurred. The patient had no history of chronic lung disease or recurrent infections. There were no constitutional symptoms. She did not take any home medications on a regular basis. She was a lifetime nontobacco user. She denied use of alcohol and illicit drugs. She had previously worked in a medical office but was now spending most of her time helping her husband take care of their house and property in Kingston, New York, a town of about 23,000 people in the Hudson River Valley. She was born in the United States and had not traveled recently. She had no pets. There was no history of recent dental procedures. She was transferred to our institution for neurosurgical evaluation.
530. Pulmonary Cavitation With Eosinophilia in a Young Man.
作者: Vinay V.;Paras Verma.;Aman Kumar.;Shibani Modi.;Sushil Kumar Munjal.
来源: Chest. 2023年164卷2期e27-e31页
An 18-year-old man with no noted medical history from Northern India presented with history of fever for 15 days and nocturnal cough for 10 days. He denied breathlessness or wheeze. There was no medical history of asthma. He denied any current sinus-related symptoms, pruritis, skin rashes, lesions, or ulcers, abdominal pain, dysphagia, vomiting or diarrhea, numbness or tingling, joint pain, or food allergy. There was no recent exposure to a patient with TB or history of substance misuse. The patient had sought medical care 7 days before presentation for the same symptoms, and after a chest radiograph was obtained, the patient was started on an antitubercular regimen.
531. Long-Term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small Cell Lung Cancer.
作者: Arvind Kumar.;Barry Xu.;Deepti Srinivasan.;Alexandra L Potter.;Vignesh Raman.;Michael Lanuti.;Chi-Fu Jeffrey Yang.;Hugh G Auchincloss.
来源: Chest. 2024年165卷3期725-737页
The American Joint Committee on Cancer (AJCC) 8th edition TNM staging manual for non-small cell lung cancer (NSCLC) M1a descriptors includes tumors presenting with malignant pleural or pericardial effusion (ie, M1a-Effusion), pleural or pericardial nodule(s) (ie, M1a-Pleural), or separate tumor nodule(s) in a contralateral lobe (ie, M1a-Contralateral).
532. Unique Changes in the Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Unravel the Role of Respiratory Pathogens: A Time Series Analysis.
作者: Zein Assad.;Zaba Valtuille.;Alexis Rybak.;Florentia Kaguelidou.;Andrea Lazzati.;Emmanuelle Varon.;Luu-Ly Pham.;Léa Lenglart.;Albert Faye.;Marion Caseris.;Robert Cohen.;Corinne Levy.;Astrid Vabret.;François Gravey.;François Angoulvant.;Bérengère Koehl.;Naïm Ouldali.
来源: Chest. 2024年165卷1期150-160页
Acute chest syndrome (ACS) is a life-threatening complication of sickle cell disease (SCD). Although respiratory pathogens are frequently detected in children with ACS, their respective role in triggering the disease is still unclear. We hypothesized that the incidence of ACS followed the unprecedented population-level changes in respiratory pathogen dynamics after COVID-19-related nonpharmaceutical interventions (NPIs).
533. The Subglottic Stenosis 6 Questionnaire: A Novel Quality-of-Life Survey Validated to Predict Need for Intervention in Patients With Idiopathic Subglottic Stenosis.
作者: Richard J Lu.;Baraa Hijaz.;Matthew R Naunheim.;Lily Stevenson.;Ramon A Franco.
来源: Chest. 2024年165卷1期161-171页
Idiopathic subglottic stenosis (iSGS) is a recurrent, chronic disease defined by fibroinflammatory narrowing of the subglottic airway. A key challenge in treatment is monitoring disease progression, which may be debilitating and unpredictable in its timing.
534. Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
作者: Daniel-Costin Marinescu.;Cameron J Hague.;Nestor L Muller.;Darra Murphy.;Andrew Churg.;Joanne L Wright.;Amna Al-Arnawoot.;Ana-Maria Bilawich.;Patrick Bourgouin.;Gerard Cox.;Celine Durand.;Tracy Elliot.;Jennifer Ellis.;Jolene H Fisher.;Derek Fladeland.;Amanda Grant-Orser.;Gillian C Goobie.;Zachary Guenther.;Ehsan Haider.;Nathan Hambly.;James Huynh.;Kerri A Johannson.;Geoffrey Karjala.;Nasreen Khalil.;Martin Kolb.;Jonathon Leipsic.;Stacey Lok.;Sarah MacIsaac.;Micheal McInnis.;Helene Manganas.;Veronica Marcoux.;John Mayo.;Julie Morisset.;Ciaran Scallan.;Tony Sedlic.;Shane Shapera.;Kelly Sun.;Victoria Tan.;Alyson W Wong.;Boyang Zheng.;Christopher J Ryerson.
来源: Chest. 2023年164卷6期1466-1475页
Clinical practice guidelines separately describe radiologic patterns of usual interstitial pneumonia (UIP) and fibrotic hypersensitivity pneumonitis (fHP), without direction on whether or how to apply these approaches concurrently within a single patient.
535. Central and Peripheral Hemodynamics in Young Adults Who Use Water Pipes and the Acute Effects of Water-Pipe Use.
作者: Hassan A Chami.;Maya Diab.;Nour Zaouk.;Samir Arnaout.;Gary F Mitchell.;Hussain Isma'eel.;Alan Shihadeh.
来源: Chest. 2023年164卷6期1481-1491页
Tobacco use via water pipe (commonly referred to as water-pipe smoking [WPS]) is popular among young adults globally and exposes those who smoke to toxicants.
536. Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
作者: Lucas R Celant.;Jeroen N Wessels.;J Tim Marcus.;Lilian J Meijboom.;Harm Jan Bogaard.;Frances S de Man.;Anton Vonk Noordegraaf.
来源: Chest. 2024年165卷1期181-191页
The 2022 European Society of Cardiology/European Respiratory Society pulmonary hypertension (PH) guidelines incorporate cardiac magnetic resonance (CMR) imaging metrics in the risk stratification of patients with pulmonary arterial hypertension (PAH). Thresholds to identify patients at estimated 1-year mortality risks of < 5%, 5% to 20%, and > 20% are introduced. However, these cutoff values are mostly single center-based and require external validation.
537. Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes.
作者: Ernesto Crisafulli.;Giulia Sartori.;Arturo Huerta.;Albert Gabarrús.;Alberto Fantin.;Néstor Soler.;Antoni Torres.
来源: Chest. 2023年164卷6期1422-1433页
Recently, the Rome proposal updated the definition of exacerbation of COPD (ECOPD). However, such severity grade has not yet demonstrated intermediate-term clinical relevance.
538. Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes.
作者: Amy L Non.;Barbara Bailey.;Surya P Bhatt.;Richard Casaburi.;Elizabeth A Regan.;Angela Wang.;Alfonso Limon.;Chantal Rabay.;Alejandro A Diaz.;Arianne K Baldomero.;Greg Kinney.;Kendra A Young.;Ben Felts.;Carol Hand.;Douglas J Conrad.
来源: Chest. 2023年164卷6期1492-1504页
Race-specific spirometry reference equations are used globally to interpret lung function for clinical, research, and occupational purposes, but inclusion of race is under scrutiny.
539. Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.
作者: Di He.;Mengsha Yan.;Yong Zhou.;Huiqing Ge.;Xuhui Zhang.;Yuying Xu.;Chengguo Liu.;Kejing Ying.;Yimin Zhu.
来源: Chest. 2024年165卷3期573-582页
COPD has been found to be associated with frailty. However, longitudinal evidence for associations of COPD with frailty progression is inadequate. Furthermore, recent studies revealed a new phenotype of lung function impairment: preserved ratio impaired spirometry (PRISm) findings. Associations of PRISm findings and their transitions with frailty progression are unclear.
540. Association Between Regular Moderate to Vigorous Physical Activity Initiation Following COPD Diagnosis and Mortality: An Emulated Target Trial Using Nationwide Cohort Data.
作者: Taeyun Kim.;Hyunsoo Kim.;Sunga Kong.;Sun Hye Shin.;Juhee Cho.;Danbee Kang.;Hye Yun Park.
来源: Chest. 2024年165卷1期84-94页
Moderate to vigorous physical activity (MVPA) in patients with COPD affects their overall health outcomes, including symptom relief and improved quality of life. However, the magnitude of the effect of MVPA initiation on real-world clinical outcomes has not been well investigated.
|